Specialized Clinical Expertise O&O Alpan specializes in conducting clinical trials with a focus on eosinophilic esophagitis and lysosomal disorders, positioning it as a key partner for pharmaceutical companies and CROs seeking access to niche therapeutic areas and efficient patient recruitment.

Strategic Industry Partnerships The company's established partnership status with major CROs like Quintiles enhances its credibility and provides priority access to multiple clinical trials, creating opportunities to offer partners expanded research support and faster project onboarding.

Growing Research Capabilities With a successful track record in patient recruitment and expanding research domains, O&O Alpan presents a valuable opportunity for sponsors looking to accelerate their clinical development timelines through experienced trial sites.

Technology Adoption Utilizing tools like Google Workspace and web hosting services, the company demonstrates a modern approach to trial management and collaboration, which is attractive for clients valuing efficient communication and data handling.

Market Position and Size Operating with a small team of 11-50 employees and generating revenue between 1M and 10M, O&O Alpan offers personalized service and agility, making it a suitable partner for organizations seeking dedicated clinical trial sites with a focused therapeutic portfolio.